BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 7, 2025
Home
»
Authors
»
Aaron Lorenzo
Articles by Aaron Lorenzo
Genome Therapeutics, Amgen Collaborate On Bone Diseases
Jan. 3, 2003
By
Aaron Lorenzo
Genome Therapeutics, Amgen Collaborate On Bone Diseases
Jan. 3, 2003
By
Aaron Lorenzo
Cellegy Enters Deal With PDL For Marketing Of Tostrex Gel
Jan. 3, 2003
By
Aaron Lorenzo
ChemoCentryx Focuses Efforts On Targeting Chemokine System
Jan. 2, 2003
By
Aaron Lorenzo
ChemoCentryx Focuses Efforts On Targeting Chemokine System
Jan. 2, 2003
By
Aaron Lorenzo
Amphora Adds $23M In Series B To Carry Out Discovery Programs
Dec. 31, 2002
By
Aaron Lorenzo
Amphora Adds $23M In Series B To Carry Out Discovery Programs
Dec. 31, 2002
By
Aaron Lorenzo
BioRexis Completes Series A Round For Peptides, Antibodies
Dec. 30, 2002
By
Aaron Lorenzo
BioRexis Completes Series A Round For Peptides, Antibodies
Dec. 30, 2002
By
Aaron Lorenzo
Transave Raises $12M For Work Targeting Diseases Of The Lung
Dec. 27, 2002
By
Aaron Lorenzo
Previous
1
2
…
210
211
212
213
214
215
216
217
218
…
237
238
Next